Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu

Jessica C. Shand, M.D., M.H.S.

Publications

Showing all 9 journal articles & 0 books available

Journal Articles

8/2018
Andolina JR, Reinish AL, Akhtar R, Noronha S, Shand JC, Girvin A, Korones DN, Bruckner LB, Mullen CA, Curran KJ, Boulad F. "Successful reduced-intensity conditioning hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia in two children." Pediatric blood & cancer.. 2018 Aug 0; 65(8):e27218. Epub 2018 May 03.

6/2018
Shand JC. ""Existential Fridays"-reflection in action." Pediatric blood & cancer.. 2018 Jun 0; 65(6):e27004. Epub 2018 Feb 22.

6/22/2017
Shand JC. "Looking up for AML in Down syndrome." Blood.. 2017 Jun 22; 129(25):3273-3274.

2016
Shand JC. "One Giant Leap for AMKL" . Blood. 2016; 127(26): 3299-300.

2014
Shand JC, Qin H, Nasholm N, Capitini CM and Fry TJ. "Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8+ T Cells. PMCID: PMC3997266; PMID: 24141010." Biol Blood Marrow Transplant. 2014; 20(1): 26-36.

2014
Shand JC, Fry TJ. "Transplantation genetics and genomics: Alloreactivity after hematopoietic stem cell transplantation. In: Murray MF, Babyatsky MW, Giovanni MA, Alkuraya FS, Stewart DR (eds)." Clinical Genomics: Practical Applications in Adult Patient Care (1st ed.), McGraw-Hill. 2014; 174.

2012
Shand JC, Berg JL, Bogue CM, lead authors. "AAP Policy Statement: Human Embryonic Stem Cell (HESC) and Human Embryo Research" . Pediatrics. 2012; 130: 1-6.

11/2010
Shand JC, Jansson J, Hsu YC, Campbell A, Mullen CA. "Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant." Cancer immunology, immunotherapy : CII.. 2010 Nov 0; 59(11):1633-44. Epub 2010 Jul 03.

10/2006
Shand JC, Mansky PJ, Brown MV, Fleisher TA, Mackall CL. "Adolescents and young adults successfully restore lymphocyte homeostasis after intensive T-cell depleting therapy for cancer." British journal of haematology.. 2006 Oct 0; 135(2):270-1.